Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort

953 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

A population-based study of cardiovascular disease mortality risk in US cancer patients. (2019, result): “Consistent with previous reports, younger age of diagnosis is associated with higher SMR, both historically and in the modern treatment era.(6) Similarly, the first year of cancer diagnosis represents the greatest risk for CVD mortality.”
ESHRE Guideline: management of women with premature ovarian insufficiency. (2016, background): “…2012; Hagman et al., 2013) D A cardiologist should be involved in care of pregnant women who have received anthracyclines and/or cardiac irradiation (Mulrooney et al., 2009; Scottish Intercollegiate Guidelines Network (SIGN), 2013) D How should fitness for pregnancy be assessed in women with POI?”
Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials (2010, background): “Although paediatric malignancies are rare, the high cure rates achieved over the last two decades has highlighted the problems which may be encountered in adult life with relation to treatment induced late effects [2-4].”
Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment (2011, background): “4-fold higher risk of developing congestive heart failure compared to those patients who did not receive anthracyclines [13].”